NCT05304442View on ClinicalTrials.gov

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Anemia, Iron DeficiencyUterine Bleeding
Interventions
DRUG

Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric]

Single Dose of IV Iron

DRUG

Ferrous Sulfate 65 mg elemental iron (325 mg tablets)

Once daily by mouth for 42 days

Trial Locations (1)

77030

RECRUITING

Ben Taub Hospital, Houston

Sponsors
All Listed Sponsors
collaborator

Pharmacosmos Therapeutics, Inc.

UNKNOWN

lead

Baylor College of Medicine

OTHER

NCT05304442 - IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department | Biotech Hunter | Biotech Hunter